Pei Renguang, Yang Min, Wang Chao, Wang Jian, Tong Xiaoqiang, Zou Yinghua
Department of Interventional Radiology and Vascular Surgery, Peking University First Hospital, Beijing, 100034, People's Republic of China.
Cardiovasc Intervent Radiol. 2018 Jun;41(6):867-871. doi: 10.1007/s00270-018-1895-2. Epub 2018 Feb 7.
To investigate the efficacy and safety of superselective transcatheter artery embolization in patients with non-ischemic priapism.
We retrospectively reviewed a cohort of 17 consecutive patients with non-ischemic priapism from September 2006 to August 2017. The median follow-up time was 8 months.
Sixteen patients underwent superselective transcatheter artery embolization, and all had complete resolution of non-ischemic priapism. Fifteen of 16 patients (93.7%) underwent a single embolization without recurrence. A secondary embolization was required in one patient (6.3%) as a result of recurrence. Two of 16 patients (12.5%) had a decrease in their erectile function; one of the two patients had premorbid erectile dysfunction. Excluding the patient with premorbid erectile dysfunction, 14 of 15 patients (93.3%) maintained premorbid normal erectile function after embolization; the incidence of decrease in quality of erection is 6.7% (1/15). One patient did not undergo artery embolization because of negative findings of cavernous fistula by angiography. No angiography-related complications were found.
Superselective transcatheter artery embolization is an effective and safe procedure for non-ischemic priapism.
探讨超选择性经导管动脉栓塞术治疗非缺血性阴茎异常勃起患者的疗效及安全性。
我们回顾性分析了2006年9月至2017年8月期间连续收治的17例非缺血性阴茎异常勃起患者。中位随访时间为8个月。
16例患者接受了超选择性经导管动脉栓塞术，所有患者的非缺血性阴茎异常勃起均完全缓解。16例患者中有15例（93.7%）接受单次栓塞后未复发。1例患者（6.3%）因复发需再次栓塞。16例患者中有2例（12.5%）勃起功能下降；其中1例患者术前存在勃起功能障碍。排除术前存在勃起功能障碍的患者，15例患者中有14例（93.3%）栓塞后维持术前正常勃起功能；勃起质量下降的发生率为6.7%（1/15）。1例患者因血管造影显示海绵体瘘阴性未接受动脉栓塞。未发现与血管造影相关的并发症。
超选择性经导管动脉栓塞术是治疗非缺血性阴茎异常勃起的一种有效且安全的方法。
